| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | Sarchi Christopher Chief Commercial Officer | Sale | -12,000 | -6.22%180,962 | $9.24 | $110,880 | View SEC filing | |
| 2026-05-20 | Xynos Konstantinos Chief Medical Officer | Sale | -14,023 | -5.62%235,662 | $5.08 | $71,237 | View SEC filing | |
| 2026-05-20 | Schwendenman Andrew Chief Accounting Officer | Sale | -7,894 | -6.87%107,057 | $5.08 | $40,102 | View SEC filing | |
| 2026-05-20 | Sarchi Christopher Chief Commercial Officer | Sale | -8,626 | -4.28%192,962 | $5.08 | $43,820 | View SEC filing | |
| 2026-05-20 | Astley-Sparke Philip Director | Sale | -17,657 | -1.23%1,412,414 | $5.08 | $89,698 | View SEC filing | |
| 2026-05-20 | Patel Sushil Chief Executive Officer | Sale | -37,324 | -4.76%747,492 | $5.08 | $189,606 | View SEC filing | |
| 2026-05-20 | Hill Emily Luisa Chief Financial Officer | Sale | -7,812 | -3.20%236,556 | $5.08 | $39,685 | View SEC filing | |
| 2026-04-06 | Sarchi Christopher Chief Commercial Officer | Sale | -6,500 | -4.11%151,588 | $8.01 | $52,065 | View SEC filing | |
| 2025-12-11 | Dhingra Kapil Director | Sale | -3,169 | -100.00%0 | $10.40 | $32,958 | View SEC filing | |
| 2025-12-04 | Patel Sushil Chief Executive Officer | Sale | -10,000 | -2.91%333,576 | $11.13 | $111,300 | View SEC filing | |
| 2025-11-19 | Sarchi Christopher Chief Commercial Officer | Sale | -5,208 | -4.06%123,088 | $9.10 | $47,393 | View SEC filing | |
| 2025-11-19 | Xynos Konstantinos Chief Medical Officer | Sale | -7,248 | -4.93%139,685 | $9.10 | $65,957 | View SEC filing | |
| 2025-08-19 | Hill Emily Luisa Chief Financial Officer | Sale | -9,154 | -6.38%134,368 | $5.37 | $49,157 | View SEC filing | |
| 2025-05-22 | Astley-Sparke Philip Director | Sale | -32,279 | -2.25%1,405,071 | $8.06 | $260,169 | View SEC filing | |
| 2025-05-22 | Xynos Konstantinos Chief Medical Officer | Sale | -7,952 | -5.13%146,933 | $8.06 | $64,093 | View SEC filing | |
| 2025-05-22 | Schwendenman Andrew Chief Accounting Officer | Sale | -3,287 | -4.59%68,284 | $8.05 | $26,460 | View SEC filing | |
| 2025-05-22 | Patel Sushil Chief Executive Officer | Sale | -25,105 | -6.81%343,576 | $8.06 | $202,346 | View SEC filing | |
| 2025-05-22 | Hill Emily Luisa Chief Financial Officer | Sale | -2,535 | -1.74%143,522 | $8.05 | $20,407 | View SEC filing | |
| 2025-05-22 | Sarchi Christopher Chief Commercial Officer | Sale | -3,749 | -2.84%128,296 | $8.05 | $30,179 | View SEC filing | |
| 2024-12-18 | Patel Sushil Chief Executive Officer | Sale | -10,000 | -4.72%202,014 | $12.42 | $124,200 | View SEC filing | |
| 2024-11-20 | Xynos Konstantinos Chief Medical Officer | Sale | -7,246 | -6.19%109,885 | $10.78 | $78,112 | View SEC filing | |
| 2024-11-20 | Sarchi Christopher Chief Commercial Officer | Sale | -5,207 | -5.64%87,045 | $10.78 | $56,131 | View SEC filing | |
| 2024-08-19 | Hill Emily Luisa Chief Financial Officer | Sale | -8,938 | -8.13%101,057 | $10.18 | $90,989 | View SEC filing | |
| 2024-06-10 | Xynos Konstantinos Chief Medical Officer | Sale | -15,881 | -11.94%117,131 | $7.50 | $119,108 | View SEC filing | |
| 2024-05-20 | Sarchi Christopher Chief Commercial Officer | Sale | -2,218 | -2.35%92,252 | $6.47 | $14,350 | View SEC filing |
1-25 of 126
